Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Med-Fine Capital

Founders Yujian Zhou

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 54
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 37
Rounds per year 5.40
Lead investments 12
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.31
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Med-Fine Capital:
Typical Co-investors
Med-Fine Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Med-Fine Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Augeo Marketing Minnesota, Saint Paul, United States
Circle Financial Group New York, New York, United States
Confluent Medical Technologies California, Fremont, United States
Curo Capital -
GEM Capital Switzerland, Zürich, Zurich
Hangzhou Longli Touzi Guanli Co., Ltd China, Hangzhou, Zhejiang
ITI Venture Capital Partners Israel, Tel Aviv, Tel Aviv District
Jotter Ventures California, Menlo Park, United States
London Stock Exchange Group England, London, United Kingdom
MAKOTO Japan, Miyagi Prefecture, Sendai
Matrimony.com Chennai, India, Tamil Nadu
Mt Vernon Investments -
Skycore Massachusetts, United States, Waltham
TMWRK New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rebbeca Med

Medical Device
$10M01 Feb 2024 Shangcheng District, Zhejiang, China

Med-Vision

Health Care
Medical
Virtual Reality
11 Jan 2023 Shangcheng District, Zhejiang, China

Leadinno Medical Valley

Medical Device
$19M31 Aug 2022 Beijing, Beijing, China

Degron Therapeutics

$22M09 Jun 2022 Shanghai, Shanghai, China

Weimi Bio-Tech

Health Care
Medical
$17M20 May 2022 Yuexiu District, Guangdong Province, China

Med-Vision

Health Care
Medical
Virtual Reality
$3M02 Apr 2022 Shangcheng District, Zhejiang, China

CorrGene

Biotechnology
Health Care
Medical
$15M28 Feb 2022 Nanjing, Jiangsu, China

Westlake Omics

Artificial Intelligence
Biotechnology
Health Care
Medical
13 Jan 2022 Hangzhou, Zhejiang, China

AccuPulse

Health Care
Health Diagnostics
Medical
$8M21 Dec 2021 Suzhou, Jiangsu, China
News
Lynk Pharmaceuticals Closes $50M Series B Financing

– Lynk Pharmaceuticals is a Hangzhou, China-based pharmaceutical R&D company.
– The company completed Series B financing of $50m.
– The round was led by Lilly Asia Ventures (LAV) with participation from New Alliance Capital and Hangzhou HEDA Biological Medicine Venture Capital Partnership (L.L.P.) and its original shareholders Legend Capital and Med-Fine Capital.
– The new investment will be used to conduct Phase I and II clinical trials for multiple programs in the R&D pipeline, expand international business, strengthen international collaborations with companies and support preclinical development of new projects.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Med-Fine Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 54
Average round size 11M
Rounds per year 5.40
Peak activity year 2020
Lead investments 12
Follow on index 0.31
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rebbeca Med

Medical Device
$10M01 Feb 2024 Shangcheng District, Zhejiang, China

Med-Vision

Health Care
Medical
Virtual Reality
11 Jan 2023 Shangcheng District, Zhejiang, China

Leadinno Medical Valley

Medical Device
$19M31 Aug 2022 Beijing, Beijing, China

Degron Therapeutics

$22M09 Jun 2022 Shanghai, Shanghai, China

Weimi Bio-Tech

Health Care
Medical
$17M20 May 2022 Yuexiu District, Guangdong Province, China

Med-Vision

Health Care
Medical
Virtual Reality
$3M02 Apr 2022 Shangcheng District, Zhejiang, China

CorrGene

Biotechnology
Health Care
Medical
$15M28 Feb 2022 Nanjing, Jiangsu, China

Westlake Omics

Artificial Intelligence
Biotechnology
Health Care
Medical
13 Jan 2022 Hangzhou, Zhejiang, China

AccuPulse

Health Care
Health Diagnostics
Medical
$8M21 Dec 2021 Suzhou, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: